Reduced apolipoprotein E-rich high-density lipoprotein level at birth is restored to the normal range in patients with familial hypercholesterolemia in the first year of life

The Journal of Clinical Endocrinology and Metabolism
Hironori NagasakaHitoshi Chiba

Abstract

High-density lipoprotein (HDL) consists of apolipoprotein E (apoE)-rich and apoE-poor HDL particles. ApoE-rich HDL level is high at birth but decreases after birth with reciprocal elevation in low-density lipoprotein (LDL)-cholesterol. The objective of the study was to clarify whether apoE-rich HDL decreases after birth in children with familial hypercholesterolemia (FH), a disorder caused by impaired LDL clearance. We measured apoE-rich HDL-cholesterol and LDL-cholesterol during the first year of life in 10 FH children (one homozygote and nine heterozygotes), 12 non-FH siblings, and 75 healthy controls. At birth, apoE-rich HDL-cholesterol was undetectable in a homozygous FH child and lower in heterozygous FH children than non-FH siblings and controls (4+/-2 vs. 12+/-4 and 11+/-4 mg/dl, P<0.001). At 3-4 months, apoE-rich HDL-cholesterol increased in homozygous and heterozygous FH children and decreased in non-FH siblings and controls. At 12 months, apoE-rich HDL-cholesterol levels were similar among these four groups (6-7 mg/dl). In contrast, LDL-cholesterol concentration was always twice as high in heterozygous FH children as non-FH siblings and controls (at birth, 50+/-15 vs. 25+/-7 and 25+/-5 mg/dl, P<0.001; at 3-4 months of...Continue Reading

References

Dec 1, 1991·Pediatric Research·X L WangN P Dudman
Apr 1, 1986·Pediatric Research·D M Lane, W J McConathy
Jan 1, 1971·Annals of Internal Medicine·W B KannelP M McNamara
Jun 6, 1998·Clinica Chimica Acta; International Journal of Clinical Chemistry·T KiyoharaK Chichibu
Sep 15, 1999·European Journal of Pediatrics·J BeesoT Peters
May 22, 2001·Science·J L Goldstein, M S Brown
Mar 8, 2002·Atherosclerosis·Hironori NagasakaKunihiko Kobayashi
Jun 25, 2002·The Journal of Laboratory and Clinical Medicine·Alpo F VuorioHelena Gylling
Sep 20, 2002·Journal of Atherosclerosis and Thrombosis·Yoshiya HataUNKNOWN Working Committee on JAS Guideline for Diagnosis and Treatment of Hyperlipidemias
Apr 26, 2003·Traffic·Petra May, Joachim Herz
Apr 28, 2006·American Journal of Human Genetics·Lin WangXin Xu
Jun 16, 2007·Arteriosclerosis, Thrombosis, and Vascular Biology·H J AvisB A Hutten

❮ Previous
Next ❯

Citations

May 26, 2009·Clinica Chimica Acta; International Journal of Clinical Chemistry·Hironori NagasakaTakashi Miida

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.